Prosthetic Joint Infection Research Models in NZW Rabbits: Opportunities for Standardization—A Systematic Review
Source abstract
Abstract
Prosthetic joint infection (PJI) is a major complication following total arthroplasty. Rising antimicrobial resistance (AMR) to antibiotics will further increase therapeutic insufficiency. New antibacterial technologies are being developed to prevent PJI. In vivo models are still needed to bridge the translational gap to clinical implementation. Though rabbit models have been used most frequently, there is no consensus about methodology and measured outcomes. The PubMed, Scopus, and EMBASE databases were searched for literature on PJI in rabbit models. Data extraction included bias control, experimental design, and outcome measures of the NZW rabbit models in the articles. A total of 60 articles were included in this systematic literature review. The articles were divided into six groups based on the PJI intervention: no intervention used (21%), revision surgery (14%), prevention with only antibiotics (21%), prevention with surface modifications (7%), prevention with coatings (23%), and others (14%). Despite the current availability of guidelines and recommendations regarding experimental design, bias control, and outcome measures, many articles neglect to report on these matters. Ultimately, this analysis aims to assist researchers in determining suitable clinically relevant methodologies and outcome measures for in vivo PJI models using NZW rabbits to test new antimicrobial technologies.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Orthopedic Infections and Treatments · Orthopaedic implants and arthroplasty · Surgical site infection prevention
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laboratory for Experimental Orthopaedics, Department of Orthopaedic Surgery, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Centre, 6229 Maastricht, The Netherlands
Department of Biomedical Engineering, Orthopaedic Biomechanics, Eindhoven University of Technology, 5612 Eindhoven, The Netherlands
Funding
Health-Holland, Top Sector Life Sciences & Health · Dutch Research Council (NWO)
References (100+)
Show source-provided references
1. Diagnosis of Periprosthetic Joint Infection Following Hip and Knee Arthroplasty10.1016/j.ocl.2016.03.001 ↗
2. Revision knee replacement for prosthetic joint infection: Epidemiology, clinical outcomes and health-economic considerations10.1016/j.knee.2020.12.024 ↗
3. The projected volume of primary and revision total knee arthroplasty will place an immense burden on future health care systems over the next 30 years10.1007/s00167-020-06154-7 ↗
4. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 203010.2106/00004623-200704000-00012 ↗
5. Epidemiology and new developments in the diagnosis of prosthetic joint infection10.5301/ijao.5000168 ↗
6. Infection associated with prosthetic joints10.1056/NEJMcp0905029 ↗
7. Implant materials and prosthetic joint infection: The battle with the biofilm10.1302/2058-5241.4.180095 ↗
8. Periprosthetic joint infection: Current concept10.4103/0019-5413.106884 ↗
9. Wei, H., Song, X., Liu, P., Liu, X., Yan, X., and Yu, L. (2022). Antimicrobial coating strategy to prevent orthopaedic device-related infections: Recent advances and future perspectives. Biomater. Adv., 135.10.1016/j.bioadv.2022.212739 ↗
10. Mortality, patient-reported outcome measures, and the health economic burden of prosthetic joint infection10.1530/EOR-23-0078 ↗
11. Etiology of implant orthopedic infections: A survey on 1027 clinical isolates10.1177/039139880502801106 ↗
12. Da Silva, R.B., and Salles, M.J. (2021). Outcomes and risk factors in prosthetic joint infections by multidrug-resistant gram-negative bacteria: A retrospective cohort study. Antibiotics, 10.10.3390/antibiotics10030340 ↗
13. Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention10.1016/j.heliyon.2018.e01067 ↗
14. Treatment options in PJI–is two-stage still gold standard?10.1016/j.jor.2020.12.021 ↗
15. Implant infections: Adhesion, biofilm formation and immune evasion10.1038/s41579-018-0019-y ↗
16. Microbial biofilm growth vs. tissue integration: “the race for the surface” experimentally studied10.1016/j.actbio.2008.12.011 ↗
17. Prevention and treatment of Staphylococcus aureus biofilms10.1586/14787210.2015.1100533 ↗
18. Paharik, A.E., and Horswill, A.R. (2016). The staphylococcal biofilm: Adhesins, regulation, and host response. Virulence Mech. Bact. Pathog., 529–566.10.1128/9781555819286.ch19 ↗
19. Biofilm tolerance, resistance and infections increasing threat of public health10.15698/mic2023.11.807 ↗
20. Salam, M.A., Al-Amin, M.Y., Salam, M.T., Pawar, J.S., Akhter, N., Rabaan, A.A., and Alqumber, M.A.A. (2023). Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare, 11.10.20944/preprints202305.0555.v1 ↗
21. Antimicrobial resistance (AMR)10.1136/ejhpharm-2018-001820 ↗
22. In vitro methods for the evaluation of antimicrobial surface designs10.1016/j.actbio.2018.02.001 ↗
23. Challenges in linking preclinical anti-microbial research strategies with clinical outcomes for device-associated infections10.22203/eCM.v028a09 ↗
24. Recommendations for design and conduct of preclinical in vivo studies of orthopedic device-related infection10.1002/jor.24230 ↗
25. Bevers, R.T., van de Voort, M.H., van Loo, I.H., Geurts, J., and Arts, J.J. (2022). The role of material technologies targeting P. aeruginosa and S. aureus quorum sensing in biofilm formation. Med. Res. Arch., 10.10.18103/mra.v10i10.3007 ↗
26. Berti, A., Rose, W., Nizet, V., and Sakoulas, G. (2020). Antibiotics and innate immunity: A cooperative effort toward the successful treatment of infections. Open Forum Infectious Diseases, Oxford University Press.10.1093/ofid/ofaa302 ↗
27. Protein binding of antimicrobials: Methods for quantification and for investigation of its impact on bacterial killing10.1208/s12248-008-9072-1 ↗
28. Hammering force during cementless total hip arthroplasty and risk of microfracture10.5301/hip.2011.8408 ↗
29. Odekerken, J.C.E. (2013). Modern Orthopaedic Implant Coatings—Their Pro’s, Con’s and Evaluation Methods. Mod. Surf. Eng. Treat., 45–73.
30. Development of a large animal rabbit model for chronic periprosthetic joint infection10.1302/2046-3758.103.BJR-2019-0193.R3 ↗
31. Animal models for implant biomaterial research in bone: A review10.22203/eCM.v013a01 ↗
32. Hickman, D., Johnson, J., Vemulapalli, T.H., Crisler, J., and Shepherd, R. (2017). Commonly used animal models. Princ. Anim. Res. Grad. Undergrad. Stud., 117–175.10.1016/B978-0-12-802151-4.00007-4 ↗
33. Rabbit as an animal model for experimental research10.4103/1735-3327.92960 ↗
34. Critical analysis of experimental models of periprosthetic joint infection10.1016/j.otsr.2015.08.007 ↗
35. Animal models of orthopaedic infections. A review of rabbit models used to induce long bone bacterial infections10.1099/jmm.0.000952 ↗
36. (2024, August 01). ARRIVE Guidelines. Available online: https://arriveguidelines.org/.
37. Minimum information in In Vivo research10.1007/164_2019_285 ↗
38. Russell and Burch’s 3Rs then and now: The need for clarity in definition and purpose
39. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews10.1136/bmj.n71 ↗
40. (2024, July 01). Covidence Systematic Review Software. Available online: www.covidence.org.
41. 2023 International Consensus Meeting on musculoskeletal infection: Summary from the treatment workgroup and consensus on treatment in preclinical models10.1002/jor.25765 ↗
42. Optimized design and analysis of preclinical intervention studies in vivo10.1038/srep30723 ↗
43. Kilkenny, C., Browne, W., Cuthill, I.C., Emerson, M., and Altman, D.G. (2011). Animal Research: Reporting In Vivo Experiments—The ARRIVE Guidelines, Sage.10.1038/jcbfm.2010.220 ↗
44. Improving bioscience research reporting: The arrive guidelines for reporting animal research10.3390/ani4010035 ↗
45. Auer, J.A., Goodship, A., Arnoczky, S., Pearce, S., Price, J., Claes, L., Von Rechenberg, B., Hofmann-Amtenbrinck, M., Schneider, E., and Müller-Terpitz, R. (2007). Refining animal models in fracture research: Seeking consensus in optimising both animal welfare and scientific validity for appropriate biomedical use. BMC Musculoskelet. Disord., 8.10.1186/1471-2474-8-72 ↗
46. Bespalov, A., Wicke, K., and Castagné, V. (2019). Blinding and randomization. Good Research Practice in Non-Clinical Pharmacology and Biomedicine, Springer.10.1007/164_2019_279 ↗
47. The welfare of animals used in science: How the “Three Rs” ethic guides improvements
48. Huang, W., Percie du Sert, N., Vollert, J., and Rice, A.S. (2020). General principles of preclinical study design. Good Research Practice in Non-Clinical Pharmacology and Biomedicine, Springer.10.1007/164_2019_277 ↗
49. Kilkenny, C., Parsons, N., Kadyszewski, E., Festing, M.F., Cuthill, I.C., Fry, D., Hutton, J., and Altman, D.G. (2009). Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PLoS ONE, 4.10.1371/journal.pone.0007824 ↗
50. Considering sex as a biological variable in preclinical research10.1096/fj.201600781r ↗
51. Kunutsor, S.K., Whitehouse, M.R., Blom, A.W., Beswick, A.D., and Team, I. (2016). Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: A systematic review and meta-analysis. PLoS ONE, 11.10.1371/journal.pone.0150866 ↗
52. Sukoff Rizzo, S.J., McTighe, S., and McKinzie, D.L. (2020). Genetic background and sex: Impact on generalizability of research findings in pharmacology studies. Good Research Practice in Non-Clinical Pharmacology and Biomedicine, Springer.10.1007/164_2019_282 ↗
53. Sex and gender analysis improves science and engineering10.1038/s41586-019-1657-6 ↗
54. Studying both sexes: A guiding principle for biomedicine10.1096/fj.15-279554 ↗
55. Methods of pairing and pair maintenance of New Zealand White rabbits (Oryctolagus cuniculus) via behavioral ethogram, monitoring, and interventions
56. Mironenko, C.M., Kapadia, M., Donlin, L., Figgie, M., Carli, A.V., Henry, M., Goodman, S.M., and Miller, A.O. (2021). 239. Sex Differences in Prosthetic Joint Infection. Open Forum Infectious Diseases, Oxford University Press.10.1093/ofid/ofab466.441 ↗
57. The Mark Coventry Award: PhotothermAA Gel Combined with Debridement, Antibiotics, and Implant Retention (DAIR) Significantly Decreases Implant Biofilm Burden and Soft-Tissue Infection in a Rabbit Model of Knee Periprosthetic Joint Infection10.1016/j.arth.2024.02.044 ↗
58. Standardized quantification of biofilm in a novel rabbit model of periprosthetic joint infection10.5194/jbji-7-91-2022 ↗
59. Weisbroth, S.H., Flatt, R.E., and Kraus, A.L. (2013). The Biology of the Laboratory Rabbit, Academic Press.
60. Early infections by myxoma virus of young rabbits (Oryctolagus cuniculus) protected by maternal antibodies activate their immune system and enhance herd immunity in wild populations10.1186/1297-9716-45-26 ↗
61. Attili, A.-R., Nebbia, P., Bellato, A., Galosi, L., Papeschi, C., Rossi, G., Linardi, M., Fileni, E., Cuteri, V., and Chiesa, F. (2020). The effect of age and sampling site on the outcome of Staphylococcus aureus infection in a rabbit (Oryctolagus cuniculus) farm in Italy. Animals, 10.10.3390/ani10050774 ↗
62. A longitudinal study of the growth of the New Zealand white rabbit: Cumulative and biweekly incremental growth rates for body length, body weight, femoral length, and tibial length10.1002/jor.1100040211 ↗
63. Rabbits and men: Relating their ages10.1515/jbcpp-2018-0002 ↗
64. A gold standard publication checklist to improve the quality of animal studies, to fully integrate the Three Rs, and to make systematic reviews more feasible10.1177/026119291003800208 ↗
65. Improving planning, design, reporting and scientific quality of animal experiments by using the Gold Standard Publication Checklist, in addition to the ARRIVE guidelines10.1111/j.1476-5381.2010.01128.x ↗
66. European Parliament, and European Council (2010). 63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. Off. J. Eur. Union, 276, 33–79.
67. Humane endpoints for laboratory animals used in regulatory testing
68. Department of Animals in Science and Society, Faculty of Veterinary Medicine Utrecht University (2024, May 29). Humane Endpoints in Laboratory Animal Experimentation. Available online: https://www.humane-endpoints.info/en.
69. A novel total knee arthroplasty infection model in rabbits10.1016/j.orthres.2005.03.007 ↗
70. Propionibacterium acnes and Staphylococcus lugdunensis cause pyogenic osteomyelitis in an intramedullary nail model in rabbits10.1128/JCM.03197-13 ↗
71. Experimental reproduction of periprosthetic joint infection: Developing a representative animal model10.1016/j.knee.2019.12.012 ↗
72. (18)F-FDG microPET imaging differentiates between septic and aseptic wound healing after orthopedic implant placement: A longitudinal study of an implant osteomyelitis in the rabbit tibia10.3109/17453674.2014.900894 ↗
73. Novel model for studying hematogenous infection in an experimental setting of implant-related infection by a community-acquired methicillin-resistant S. aureus strain10.1002/jor.20608 ↗
74. Evaluation of 99mTc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection
75. Evaluation of 99mTc-UBI 29-41 scintigraphy for specific detection of experimental Staphylococcus aureus prosthetic joint infections10.1007/s00259-007-0368-7 ↗
76. Technetium-99m-labeled annexin V imaging for detecting prosthetic joint infection in a rabbit model10.7555/JBR.29.20130113 ↗
77. Using18F-flurodeoxyglucose and68Ga-fibroblast activation protein inhibitor PET/CT to evaluate a new periprosthetic joint infection model of rabbit due to Staphylococcus aureus10.1097/MNM.0000000000001495 ↗
78. Wang, Y., Li, Y., Han, L., Wang, J., Zhang, C., Qi, E., Zhang, D., Zhang, X., Huan, Y., and Tian, J. (2022). 18F-FDG and 68 Ga-FAPI PET/CT for the evaluation of periprosthetic joint infection and aseptic loosening in rabbit models. BMC Musculoskelet. Disord., 23.10.1186/s12891-022-05537-w ↗
79. A new small animal model for simulating a two-stage-revision procedure in implant-related methicillin-resistant Staphylococcus aureus bone infection10.1016/j.injury.2019.08.017 ↗
80. Treatment of experimental osteomyelitis by Methicillin Resistant Staphylococcus aureus with bone cement system releasing grepafloxacin10.1016/j.injury.2008.04.006 ↗
81. Colistin-containing cement spacer for treatment of experimental carbapenemase-producing Klebsiella pneumoniae prosthetic joint infection10.1016/j.ijantimicag.2019.07.009 ↗
82. Teicoplanin-containing cement spacers for treatment of experimental Staphylococcus aureus joint prosthesis infection10.1128/AAC.47.10.3365-3367.2003 ↗
83. The tale of microencapsulated rifampicin: Is it useful for the treatment of periprosthetic joint infection?10.1007/s00264-021-05290-0 ↗
84. Tobramycin-containing bone cement and systemic cefazolin in a one-stage revision. Treatment of infection in a rabbit model10.1002/jbm.1073 ↗
85. Local gentamicin delivery from resorbable viscous hydrogels is therapeutically effective10.1007/s11999-014-3935-9 ↗
86. Continuous wave ultrasound enhances vancomycin release and antimicrobial efficacy of antibiotic-loaded acrylic bone cement in vitro and in vivo10.1002/jbm.b.30705 ↗
87. Evaluation of antibiotic-impregnated microspheres for the prevention of implant-associated orthopaedic infections10.2106/JBJS.L.01750 ↗
88. Evaluation and comparison of the antimicrobial efficacy of teicoplanin- and clindamycin-coated titanium implants: An experimental study10.1302/0301-620X.92B1.22134 ↗
89. In vivo efficacy of antimicrobial-coated devices10.2106/00004623-200704000-00014 ↗
90. Ceftaroline-Fosamil efficacy against methicillin-resistant Staphylococcus aureus in a rabbit prosthetic joint infection model10.1128/AAC.03600-14 ↗
91. Efficacy of antibacterial-loaded coating in an in vivo model of acutely highly contaminated implant10.1007/s00264-013-2237-2 ↗
92. Establishment of a new methicillin resistant Staphylococcus aureus animal model of osteomyelitis10.1007/s00264-013-2149-1 ↗
93. The immobilization of antibiotic-loaded polymeric coatings on osteoarticular Ti implants for the prevention of bone infections10.1039/C7BM00693D ↗
94. Gentamicin coating of nanotubular anodized titanium implant reduces implant-related osteomyelitis and enhances bone biocompatibility in rabbits10.2147/IJN.S137137 ↗
95. Bactericidal activity of the combination of levofloxacin with rifampin in experimental prosthetic knee infection in rabbits due to methicillin-susceptible Staphylococcus aureus10.1128/AAC.01163-08 ↗
96. Combination of quinupristin-dalfopristin (synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection10.1128/AAC.46.4.1122-1124.2002 ↗
97. Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus10.1128/AAC.00675-11 ↗
98. Implant stability in the treatment of MRSA bone implant infections with linezolid versus vancomycin in a rabbit model10.1002/jor.21516 ↗
99. Staphylococcus aureus Prosthetic Joint Infection Is Prevented by a Fluorine- and Phosphorus-Doped Nanostructured Ti-6Al-4V Alloy Loaded With Gentamicin and Vancomycin10.1002/jor.24496 ↗
100. Infection resistance of unreamed solid, hollow slotted and cannulated intramedullary nails: An in-vivo experimental comparison10.1016/j.orthres.2004.11.006 ↗